300 related articles for article (PubMed ID: 25876024)
1. Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR.
Ciarloni L; Hosseinian S; Monnier-Benoit S; Imaizumi N; Dorta G; Ruegg C;
PLoS One; 2015; 10(4):e0123904. PubMed ID: 25876024
[TBL] [Abstract][Full Text] [Related]
2. A novel gene expression signature in peripheral blood mononuclear cells for early detection of colorectal cancer.
Nichita C; Ciarloni L; Monnier-Benoit S; Hosseinian S; Dorta G; Rüegg C
Aliment Pharmacol Ther; 2014 Mar; 39(5):507-17. PubMed ID: 24428642
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps.
Cassinotti E; Melson J; Liggett T; Melnikov A; Yi Q; Replogle C; Mobarhan S; Boni L; Segato S; Levenson V
Int J Cancer; 2012 Sep; 131(5):1153-7. PubMed ID: 22020530
[TBL] [Abstract][Full Text] [Related]
4. Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer.
Ciarloni L; Ehrensberger SH; Imaizumi N; Monnier-Benoit S; Nichita C; Myung SJ; Kim JS; Song SY; Kim TI; van der Weg B; Meier R; Borovicka J; Beglinger C; Vallet C; Maerten P; Rüegg C; Dorta G
Clin Cancer Res; 2016 Sep; 22(18):4604-11. PubMed ID: 27126992
[TBL] [Abstract][Full Text] [Related]
5. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
[TBL] [Abstract][Full Text] [Related]
6. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
Luo X; Wu Y; Ji M; Zhang S
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
[TBL] [Abstract][Full Text] [Related]
7. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
[TBL] [Abstract][Full Text] [Related]
8. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
9. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
10. CA11-19: a tumor marker for the detection of colorectal cancer.
Overholt BF; Wheeler DJ; Jordan T; Fritsche HA
Gastrointest Endosc; 2016 Mar; 83(3):545-51. PubMed ID: 26318832
[TBL] [Abstract][Full Text] [Related]
11. A novel method for screening colorectal cancer by infrared spectroscopy of peripheral blood mononuclear cells and plasma.
Barlev E; Zelig U; Bar O; Segev C; Mordechai S; Kapelushnik J; Nathan I; Flomen F; Kashtan H; Dickman R; Madhala-Givon O; Wasserberg N
J Gastroenterol; 2016 Mar; 51(3):214-21. PubMed ID: 26112122
[TBL] [Abstract][Full Text] [Related]
12. Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy.
Jobin G; Rodriguez-Suarez R; Betito K
Gastroenterology; 2017 Oct; 153(4):980-987. PubMed ID: 28625834
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer.
Pack SC; Kim HR; Lim SW; Kim HY; Ko JY; Lee KS; Hwang D; Park SI; Kang H; Park SW; Hong GY; Hwang SM; Shin MG; Lee S
Int J Colorectal Dis; 2013 Jan; 28(1):139-47. PubMed ID: 22990173
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
[TBL] [Abstract][Full Text] [Related]
16. Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.
Wilhelmsen M; Christensen IJ; Rasmussen L; Jørgensen LN; Madsen MR; Vilandt J; Hillig T; Klaerke M; Nielsen KT; Laurberg S; Brünner N; Gawel S; Yang X; Davis G; Heijboer A; Martens F; Nielsen HJ
Int J Cancer; 2017 Mar; 140(6):1436-1446. PubMed ID: 27935033
[TBL] [Abstract][Full Text] [Related]
17. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.
Rahier JF; Druez A; Faugeras L; Martinet JP; Géhénot M; Josseaux E; Herzog M; Micallef J; George F; Delos M; De Ronde T; Badaoui A; D'Hondt L
Clin Epigenetics; 2017; 9():53. PubMed ID: 28515797
[TBL] [Abstract][Full Text] [Related]
18. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.
Rodia MT; Solmi R; Pasini F; Nardi E; Mattei G; Ugolini G; Ricciardiello L; Strippoli P; Miglio R; Lauriola M
Clin Colorectal Cancer; 2018 Jun; 17(2):e217-e228. PubMed ID: 29352642
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
[TBL] [Abstract][Full Text] [Related]
20. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
